{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T21:38:35Z","timestamp":1774042715010,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1"],"award-info":[{"award-number":["\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Antibody-negative combined central and peripheral demyelination (CCPD) is a rare neuroimmunological disorder with heterogeneous manifestations and variable treatment response. We report a case of a 40-year-old man who developed acute hypercapnic respiratory failure following influenza A infection. Neuroimaging revealed demyelinating lesions in the brainstem and spinal cord, and nerve conduction studies showed multifocal peripheral demyelination. Peripheral immune profiling demonstrated marked B-cell activation and elevated serum interleukin-6 (IL-6). The patient responded poorly to corticosteroids, intravenous immunoglobulin, and plasma exchange, but improved rapidly after two consecutive daily doses of 100 mg rituximab (RTX), which was accompanied by a significant reduction in IL-6 levels, CD19<jats:sup>+<\/jats:sup> B-cell depletion, ventilator weaning, and marked neurological recovery. This case underscores the importance of considering neuroimmunological causes in acute hypercapnic respiratory failure of unclear etiology. The close temporal association between IL-6 decline, B-cell depletion, and clinical improvement suggests that the B-cell\u2013IL-6 axis may play a central role in antibody-negative CCPD pathogenesis. Low-dose RTX may represent a safe and effective therapeutic option in refractory cases.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1682211","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:31:03Z","timestamp":1760679063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rituximab for antibody-negative combined central and peripheral demyelination presenting with acute respiratory failure: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuanjiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/ene.15628","article-title":"Immune-mediated diseases involving central and peripheral nervous systems","volume":"30","author":"Leboyan","year":"2023","journal-title":"Eur J Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.02.022","article-title":"Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment","volume":"363","author":"Cortese","year":"2016","journal-title":"J Neurol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp-2014-309831","article-title":"A nationwide survey of combined central and peripheral demyelination in Japan","volume":"87","author":"Ogata","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e200206","DOI":"10.1212\/NXI.0000000000200206","article-title":"CD11chigh B cell expansion is associated with severity and brain atrophy in neuromyelitis optica","volume":"11","author":"Amano","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2022.102643","article-title":"Targeting B cell dysregulation with emerging therapies in autoimmune demyelinating disorders","volume":"77","author":"Liyanage","year":"2022","journal-title":"Curr Opin Neurobiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211028126","article-title":"The clinical features of combined central and peripheral demyelination and antibodies against the node of Ranvier","volume":"28","author":"Hou","year":"2022","journal-title":"Mult Scler"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imr.12091","article-title":"Virus infection, antiviral immunity, and autoimmunity","volume":"255","author":"Getts","year":"2013","journal-title":"Immunol Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.09.009","article-title":"Identification and management of acute neuromuscular respiratory failure in the ICU","volume":"164","author":"Krall","year":"2023","journal-title":"Chest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13054-020-2776-z","article-title":"Physiology of the respiratory drive in ICU patients: implications for diagnosis and treatment","volume":"24","author":"Jonkman","year":"2020","journal-title":"Crit Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S1474-4422(24)00077-2","article-title":"Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial","volume":"23","author":"Cree","year":"2024","journal-title":"Lancet Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e70126","DOI":"10.1111\/cns.70126","article-title":"First-in-human study of BAT4406F, an ADCC-enhanced fully humanized anti-CD20 monoclonal antibody in patients with neuromyelitis optica spectrum disorders","volume":"30","author":"Yu","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081787","article-title":"Infection and activation of B cells by Theiler\u2019s murine encephalomyelitis virus (TMEV) leads to autoantibody production in an infectious model of multiple sclerosis","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"358:577637","DOI":"10.1016\/j.jneuroim.2021.577637","article-title":"EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines","author":"Baek","year":"2021","journal-title":"J Neuroimmunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.680581","article-title":"The role of B cells in primary progressive multiple sclerosis","volume":"12","author":"Holloman","year":"2021","journal-title":"Front Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28575","article-title":"The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2\/STAT3 pathway","volume":"234","author":"Couto","year":"2019","journal-title":"J Cell Physiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301906","article-title":"IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages","volume":"192","author":"Kothari","year":"2014","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.010","article-title":"Foxo3 transcription factor drives pathogenic T helper 1 differentiation by inducing the expression of eomes","volume":"45","author":"Stienne","year":"2016","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102905","article-title":"New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation","volume":"11","author":"Greigert","year":"2022","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30078-8","article-title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial","volume":"19","author":"Traboulsee","year":"2020","journal-title":"Lancet Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(20)30070-3","article-title":"Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial","volume":"19","author":"Zhang","year":"2020","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00120","article-title":"IL-6 in the cerebrospinal fluid signals disease activity in multiple sclerosis","volume":"14","author":"Stampanoni Bassi","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12883-025-04145-0","article-title":"Intrathecal interleukin-6 levels are associated with progressive disease and clinical severity in multiple sclerosis","volume":"25","author":"Itorralba","year":"2025","journal-title":"BMC Neurol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101460","article-title":"Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy","volume":"37","author":"Hoshino","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515623862","article-title":"MS arising during Tocilizumab therapy for rheumatoid arthritis","volume":"22","author":"Beauchemin","year":"2016","journal-title":"Mult Scler"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.966766","article-title":"Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases","volume":"13","author":"Jiao","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/11795735211039913","article-title":"Optic nerve demyelination in igG4 anti-neurofascin 155 antibody-positive combined central and peripheral demyelination syndrome","volume":"13","author":"Verghese","year":"2021","journal-title":"J Cent Nerv Syst Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2015.238","article-title":"Fulminant central plus peripheral nervous system demyelination without antibodies to neurofascin","volume":"43","author":"Vural","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000388","article-title":"Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination","volume":"7","author":"Savasta","year":"2017","journal-title":"Neurol Clin Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1288546","article-title":"Combined central and peripheral demyelination: a case report resembling encephalomyeloradiculoneuropathy","volume":"14","author":"Zhou","year":"2024","journal-title":"Front Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102926","article-title":"Atypical inflammatory demyelinating syndrome with central and peripheral nerve involvement","volume":"51","author":"Farag","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e14690","DOI":"10.7759\/cureus.14690","article-title":"Combined central and peripheral demyelinating disease with good response to B-cell depleting therapy","volume":"13","author":"Makkawi","year":"2021","journal-title":"Cureus"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106961","article-title":"A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody","volume":"210","author":"Sokmen","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000313","article-title":"A case of combined central and peripheral demyelination associated with antineurofascin 155 antibodies and paternal history of multiple sclerosis","volume":"26","author":"Lambrianides","year":"2021","journal-title":"Neurologist"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:31:04Z","timestamp":1760679064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1682211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2025.1682211"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1682211","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"article-number":"1682211"}}